The question is which benefit matters more to you and whether that priority might shift as your goals, lifestyle, or budget change
Most people experience mild nausea during these first few weeks, typically lasting a day or two after each injection
The publisher or author may receive compensation through affiliate commissions if a purchase is made through these links
FDA Status: Approved for type 2 diabetes (Mounjaro) and for chronic weight management (Zepbound) How It Works: Activates both GLP-1 and GIP receptors to increase energy expenditure, improve metabolic efficiency, and suppress appetite more effectively Common Side Effects: Nausea, vomiting, fatigue, and mild digestive discomfort (typically improving with time) Typical Weight Loss Results: Clinical studies show up to 2022% reduction in body weight with proper diet and exercise support Tirzepatides dual mechanism of action has made it a favorite among clinicians seeking greater results for patients struggling with obesity or insulin resistance
Stepping back, I feel oral Wegovy is behaving more like an inflection product for Novo Nordisk
also supports mineral metabolism balance to help maintain skeletal stability